Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Free Cash Flow for the year ending December 31, 2023: USD -91.74 M

Lifecome Biochemistry Co.,Ltd. Free Cash Flow is USD -91.74 M for the year ending December 31, 2023, a -333.14% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Lifecome Biochemistry Co.,Ltd. Free Cash Flow for the year ending December 31, 2022 was USD -21.18 M, a 58.21% change year over year.
Lifecome Biochemistry Co.,Ltd. Free Cash Flow for the year ending December 31, 2021 was USD -50.68 M, a -102.85% change year over year.
Lifecome Biochemistry Co.,Ltd. Free Cash Flow for the year ending December 31, 2020 was USD -24.98 M, a -237.72% change year over year.
Lifecome Biochemistry Co.,Ltd. Free Cash Flow for the year ending December 31, 2019 was USD -7.40 M, a -246.34% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years